Patrick J Morris

8PUBLICATIONS
44CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 02, 2026
Kinome profiling enabled development of a LATS1/2 inhibitor with wound healing potential.

|Dec 18, 2025
An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors.

Ana Corrionero, Xiaohu Zhang, Patricia Alfonso

|Aug 06, 2025
Discovery and Optimization of LATS1 and LATS2 Kinase Inhibitors for Use in Regenerative Medicine.

Patrick J Morris, Damien Y Duveau, Michele Ceribelli

|Feb 03, 2022
Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2,6)- and (5R)-Methyl-(2R,6R)-hydroxynorketamines.

Jaclyn N Highland, Patrick J Morris, Kylie M Konrath

|Nov 22, 2019
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.

Grant L Lin, Kelli M Wilson, Michele Ceribelli

|Jul 13, 2018
miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential.

Sara E Meyer, David E Muench, Andrew M Rogers

Pageof 2

Frequent Collaborators

5 joint publications

Craig J Thomas

3 joint publications

Scott B Hoyt

2 joint publications

Lale Evsen

2 joint publications

Christopher A LeClair